Joel Selzer

Bio:

Joel helps trial sponsors turn human performance risk into a manageable, measurable variable. As CEO of ArcheMedX, he leads the team behind Ready -- a behavioral science-based readiness intelligence platform used by over 300,000 clinical professionals across 90+ countries.

A technology entrepreneur and innovator with over 20 years building companies at the intersection of data and life sciences, Joel speaks regularly on how behavioral science and predictive analytics are reshaping what trial readiness actually means -- and how the sponsors moving fastest got there by seeing risk before it became a problem. He holds a BA from Georgetown and an MBA from UVA's Darden School of Business.